Advanced in Heart Failure

Eva M. Lonn

Hamilton, ON, CA 
Advanced in Heart Failure
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Eva Lonn practices in Hamilton, Canada. Ms. Lonn is rated as an Advanced expert by MediFind in the treatment of Heart Failure. Her top areas of expertise are Heart Failure, Coronary Heart Disease, Stroke, and Atherosclerosis.

Her clinical research consists of co-authoring 116 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles and participated in 2 clinical trials in the study of Heart Failure.

Gender
Female

Locations

Hamilton, ON, Canada
Other Locations
Hamilton, Canada
Quebec, QC, Canada
Calgary, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Global Congestive Heart Failure Registry
Global Congestive Heart Failure Registry
Enrollment Status: Completed
Publish Date: August 22, 2024
The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure
The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Other
Study Phase: Phase 3
The International Polycap Study 3 (TIPS-3) is a Randomized Double-blind Placebo-controlled Trial for the Evaluation of a Polycap, Low Dose Aspirin and Vitamin D Supplementation in Primary Prevention
The International Polycap Study 3 (TIPS-3) is a Randomized Double-blind Placebo-controlled Trial for the Evaluation of a Polycap, Low Dose Aspirin and Vitamin D Supplementation in Primary Prevention
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Drugs: Polycap (thiazide 25mg, atenolol 100mg, ramipril 10mg, simvastatin 40mg), Aspirin, Vitamin D
Study Phase: Phase 3
View 3 Less Clinical Trials

116 Total Publications

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement.
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement.
Journal: European heart journal
Published: May 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lonn's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile